MedTrace Logo

A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia

NCT05637229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-10-31

No results posted yet for this study

Summary

This study is a sero-survey study of infants aged 6 months to 71 months in Bandung City and West Bandung District. As initial data to find out how many children have been exposed to human enterovirus type 71 (HEV-71) which causes Hand, foot, and mouth disease (HFMD).

Conditions

  • Hand, Foot and Mouth Disease

Sponsors & Collaborators

  • Sinovac Biotech Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Rodman Tarigan, Doctor · Hasan Sadikin Hospital/School of Medicine, Padjadjaran University, Bandung

Eligibility

Min Age
6 Months
Max Age
71 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2022-12-19
Completion
2022-12-19

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05637229 on ClinicalTrials.gov